Cargando…

Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

Detalles Bibliográficos
Autores principales: Carpenedo, Monica, Zappaterra, Arianna, Ferrari, Beatrice, Cotilli, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000878/
https://www.ncbi.nlm.nih.gov/pubmed/36908865
http://dx.doi.org/10.4084/MJHID.2023.021
_version_ 1784903992039440384
author Carpenedo, Monica
Zappaterra, Arianna
Ferrari, Beatrice
Cotilli, Giulia
author_facet Carpenedo, Monica
Zappaterra, Arianna
Ferrari, Beatrice
Cotilli, Giulia
author_sort Carpenedo, Monica
collection PubMed
description
format Online
Article
Text
id pubmed-10000878
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-100008782023-03-11 Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists Carpenedo, Monica Zappaterra, Arianna Ferrari, Beatrice Cotilli, Giulia Mediterr J Hematol Infect Dis Letter to the Editor Università Cattolica del Sacro Cuore 2023-03-01 /pmc/articles/PMC10000878/ /pubmed/36908865 http://dx.doi.org/10.4084/MJHID.2023.021 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Carpenedo, Monica
Zappaterra, Arianna
Ferrari, Beatrice
Cotilli, Giulia
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_full Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_fullStr Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_full_unstemmed Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_short Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multi-Refractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_sort sequential use of efgartigimod and romiplostim restored platelet response in two multi-refractory thrombocytopenic patients, previously treated with thrombopoietin receptor agonists
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000878/
https://www.ncbi.nlm.nih.gov/pubmed/36908865
http://dx.doi.org/10.4084/MJHID.2023.021
work_keys_str_mv AT carpenedomonica sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT zappaterraarianna sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT ferraribeatrice sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT cotilligiulia sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists